The authors discovered that the deletion of E3 ubiquitin ligase Cop1 sensitised TNBC 4T1 tumours as well as the murine tumour models EMT6 (TNBC) and MC38 (colon) to immunotherapy. This evidence concerns the gene COP1 and neoplasm.